Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system

Circulation Research

Volumn 110, Issue 10, 2012, Pages 1364-1390

  Lassègue, Bernard ^a   San Martín, Alejandra ^a   Griendling, Kathy K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; cardiac hypertrophy; cardiomyocytes; cardiovascular disease; endothelial cells; hypertension; NADPH oxidases; reactive oxygen species; redox; vascular smooth muscle

Indexed keywords

ALDOSTERONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OXIDOREDUCTASE INHIBITOR; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; SPIRONOLACTONE; UNCLASSIFIED DRUG; VAS 2870;

ANGIOGENESIS; ANTIHYPERTENSIVE THERAPY; APOPTOSIS; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR SYSTEM; CELL FUNCTION; CELL PROLIFERATION; CHRONIC GRANULOMATOUS DISEASE; COLLATERAL CIRCULATION; CYTOSOL; ENDOPLASMIC RETICULUM; ESSENTIAL HYPERTENSION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RENOVASCULAR HYPERTENSION; REPERFUSION INJURY; REVIEW; STROKE;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; ENDOTHELIUM, VASCULAR; HUMANS; NADPH OXIDASE; REACTIVE OXYGEN SPECIES;

EID: 84861062943     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.243972     Document Type: Review

References (386)

1. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87: 245-313. (Pubitemid 46209993)
2. Bayraktutan U, Blayney L, Shah AM. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20: 1903-1911. (Pubitemid 30644639)
3. Hohler B, Holzapfel B, Kummer W. NADPH oxidase subunits and superoxide production in porcine pulmonary artery endothelial cells. Histochem Cell Biol. 2000;114:29-37. (Pubitemid 30609854)
4. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol. 2003;285: R277-R297. (Pubitemid 36898897)
5. Sumimoto H. Structure, regulation and evolution of nox-family NADPH oxidases that produce reactive oxygen species. FEBS J. 2008;275: 3249-3277. (Pubitemid 351813551)
6. Biberstine-Kinkade KJ, DeLeo FR, Epstein RI, LeRoy BA, Nauseef WM, Dinauer MC. Heme-ligating histidines in flavocytochrome b(558): identification of specific histidines in gp91(phox). J Biol Chem. 2001; 276:31105-31112.
7. Lassegue B, Griendling KK. Reactive oxygen species in hypertension; an update. Am J Hypertens. 2004;17:852-860. (Pubitemid 39201104)
8. DeCoursey TE. Voltage-gated proton channels find their dream job managing the respiratory burst in phagocytes. Physiology. 2010;25: 27-40.
9. Moreland JG, Davis AP, Bailey G, Nauseef WM, Lamb FS. Anion channels, including clc-3, are required for normal neutrophil oxidative function, phagocytosis, and transendothelial migration. J Biol Chem. 2006;281:12277-12288. (Pubitemid 43855312)
10. Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, van Leeuwen K, Koker MY, Wolach B, Roesler J, Malech HL, Holland SM, Gallin JI, Stasia MJ. Hematologically important mutations: The autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44:291-299.
11. Roos D, Kuhns DB, Maddalena A, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45:246-265.
12. Kao YY, Gianni D, Bohl B, Taylor RM, Bokoch GM. Identification of a conserved rac-binding site on NADPH oxidases supports a direct gtpase regulatory mechanism. J Biol Chem. 2008;283:12736-12746.
13. Lapouge K, Smith SJ, Groemping Y, Rittinger K. Architecture of the p40-p47-p67phox complex in the resting state of the NADPH oxidase: A central role for p67phox. J Biol Chem. 2002;277:10121-10128. (Pubitemid 34968123)
14. Raad H, Paclet MH, Boussetta T, Kroviarski Y, Morel F, Quinn MT, Gougerot-Pocidalo MA, Dang PM, El-Benna J. Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/nox2 by protein kinase C enhances its diaphorase activity and binding to rac2, p67phox, and p47phox. FASEB J. 2009;23:1011-1022.
15. Ueyama T, Kusakabe T, Karasawa S, Kawasaki T, Shimizu A, Son J, Leto TL, Miyawaki A, Saito N. Sequential binding of cytosolic phox complex to phagosomes through regulated adaptor proteins: evaluation using the novel monomeric kusabira-green system and live imaging of phagocytosis. J Immunol. 2008;181:629-640.
16. Ago T, Nunoi H, Ito T, Sumimoto H. Mechanism for phosphorylationinduced activation of the phagocyte NADPH oxidase protein p47(phox): Triple replacement of serines 303, 304, and 328 with aspartates disrupts the sh3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase. J Biol Chem. 1999;274:33644-33653. (Pubitemid 129511677)
17. Reeves EP, Dekker LV, Forbes LV, Wientjes FB, Grogan A, Pappin DJ, Segal AW. Direct interaction between p47phox and protein kinase C: evidence for targeting of protein kinase c by p47phox in neutrophils. Biochem J. 1999;344:859-866. (Pubitemid 30032535)
18. Dang PM, Fontayne A, Hakim J, El Benna J, Perianin A. Protein kinase c zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. J Immunol. 2001;166:1206-1213. (Pubitemid 32060281)
19. Fontayne A, Dang PM, Gougerot-Pocidalo MA, El-Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry. 2002;41:7743-7750. (Pubitemid 34627801)
20. Ago T, Kuribayashi F, Hiroaki H, Takeya R, Ito T, Kohda D, Sumimoto H. Phosphorylation of p47phox directs phox homology domain from sh3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation. Proc Natl Acad Sci U S A. 2003;100:4474-4479. (Pubitemid 36457755)
21. Hoyal CR, Gutierrez A, Young BM, Catz SD, Lin JH, Tsichlis PN, Babior BM. Modulation of p47phox activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase. Proc Natl Acad Sci U S A. 2003;100:5130-5135. (Pubitemid 36542670)
22. Chen Q, Powell DW, Rane MJ, Singh S, Butt W, Klein JB, McLeish KR. Akt phosphorylates p47phox and mediates respiratory burst activity in human neutrophils. J Immunol. 2003;170:5302-5308. (Pubitemid 36554765)
23. Martyn KD, Kim MJ, Quinn MT, Dinauer MC, Knaus UG. P21-activated kinase (PAK) regulates NADPH oxidase activation in human neutrophils. Blood. 2005;106:3962-3969. (Pubitemid 41739039)
24. Frey RS, Rahman A, Kefer JC, Minshall RD, Malik AB. Pkczeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res. 2002;90:1012-1019. (Pubitemid 34633868)
25. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res. 2002;90: 1205-1213. (Pubitemid 34786906)
26. Li JM, Shah AM. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II: role of the p47phox subunit. J Biol Chem. 2003;278:12094-12100. (Pubitemid 36800187)
27. Touyz RM, Yao G, Schiffrin EL. C-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2003;23:981-987. (Pubitemid 36717143)
28. Chowdhury AK, Watkins T, Parinandi NL, Saatian B, Kleinberg ME, Usatyuk PV, Natarajan V. Src-mediated tyrosine phosphorylation of p47phox in hyperoxia-induced activation of NADPH oxidase and generation of reactive oxygen species in lung endothelial cells. J Biol Chem. 2005;280:20700-20711. (Pubitemid 40776775)
29. Kanai F, Liu H, Field SJ, Akbary H, Matsuo T, Brown GE, Cantley LC, Yaffe MB. The px domains of p47phox and p40phox bind to lipid products of pi(3)k. Nat Cell Biol. 2001;3:675-678. (Pubitemid 32624424)
30. Zhan Y, He D, Newburger PE, Zhou GW. P47(phox) px domain of NADPH oxidase targets cell membrane via moesin-mediated association with the actin cytoskeleton. J Cell Biochem. 2004;92:795-809. (Pubitemid 44264269)
31. Touyz RM, Yao G, Quinn MT, Pagano PJ, Schiffrin EL. P47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol. 2005;25:512-518. (Pubitemid 40315671)
32. Van Buul JD, Fernandez-Borja M, Anthony EC, Hordijk PL. Expression and localization of nox2 and nox4 in primary human endothelial cells. Antioxidant Redox Signal. 2005;7:308-317. (Pubitemid 40279800)
33. Groemping Y, Lapouge K, Smerdon SJ, Rittinger K. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell. 2003; 113:343-355. (Pubitemid 36556116)
34. Ogura K, Nobuhisa I, Yuzawa S, Takeya R, Torikai S, Saikawa K, Sumimoto H, Inagaki F. NMR solution structure of the tandem Src homology 3 domains of p47phox complexed with a p22phox-derived proline-rich peptide. J Biol Chem. 2006;281:3660-3668. (Pubitemid 43845984)
35. Huang CK, Zhan L, Hannigan MO, Ai Y, Leto TL. P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, c57bl/6j-m db/db and db/+. J Leukoc Biol. 2000;67:210-215.
36. Jackson SH, Gallin JI, Holland SM. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med. 1995;182: 751-758.
37. Harbord M, Novelli M, Canas B, Power D, Davis C, Godovac- Zimmermann J, Roes J, Segal AW. Ym1 is a neutrophil granule protein that crystallizes in p47phox-deficient mice. J Biol Chem. 2002;277: 5468-5475. (Pubitemid 34968596)
38. Freeman JL, Lambeth JD. NADPH oxidase activity is independent of p47phox in vitro. J Biol Chem. 1996;271:22578-22582. (Pubitemid 26304697)
39. Nisimoto Y, Motalebi S, Han CH, Lambeth JD. The p67(phox) activation domain regulates electron flow from NADPH to flavin in flavocytochrome b(558). J Biol Chem. 1999;274:22999-23005.
40. Ponting CP. Novel domains in NADPH oxidase subunits, sorting nexins, and ptdins 3-kinases: binding partners of sh3 domains? Prot Sci. 1996; 5:2353-2357. (Pubitemid 26384474)
41. Leusen JH, de Klein A, Hilarius PM, Ahlin A, Palmblad J, Smith CI, Diekmann D, Hall A, Verhoeven AJ, Roos D. Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease. J Exp Med. 1996;184:1243-1249. (Pubitemid 26354679)
42. Koga H, Terasawa H, Nunoi H, Takeshige K, Inagaki F, Sumimoto H. Tetratricopeptide repeat (tpr) motifs of p67(phox) participate in interaction with the small gtpase rac and activation of the phagocyte NADPH oxidase. J Biol Chem. 1999;274:25051-25060.
43. Alloul N, Gorzalczany Y, Itan M, Sigal N, Pick E. Activation of the superoxide-generating NADPH oxidase by chimeric proteins consisting of segments of the cytosolic component p67(phox) and the small gtpase rac1. Biochemistry. 2001;40:14557-14566. (Pubitemid 33111739)
44. Han CH, Freeman JL, Lee T, Motalebi SA, Lambeth JD. Regulation of the neutrophil respiratory burst oxidase: identification of an activation domain in p67(phox). J Biol Chem. 1998;273:16663-16668. (Pubitemid 28311688)
45. Yuzawa S, Miyano K, Honbou K, Inagaki F, Sumimoto H. The domain organization of p67 phox, a protein required for activation of the superoxide-producing NADPH oxidase in phagocytes. J Innate Immunity. 2009;1:543-555.
46. Nakamura R, Sumimoto H, Mizuki K, Hata K, Ago T, Kitajima S, Takeshige K, Sakaki Y, Ito T. The PC motif: A novel and evolutionarily conserved sequence involved in interaction between p40phox and p67phox, sh3 domain-containing cytosolic factors of the phagocyte NADPH oxidase. Eur J Biochem/FEBS. 1998;251:583-589. (Pubitemid 28108950)
47. Kuribayashi F, Nunoi H, Wakamatsu K, Tsunawaki S, Sato K, Ito T, Sumimoto H. The adaptor protein p40(phox) as a positive regulator of the superoxide-producing phagocyte oxidase. EMBO J. 2002;21: 6312-6320. (Pubitemid 35448409)
48. Leto TL, Adams AG, de Mendez I. Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. Proc Natl Acad Sci U S A. 1994;91:10650-10654. (Pubitemid 24329056)
49. Finan P, Shimizu Y, Gout I, Hsuan J, Truong O, Butcher C, Bennett P, Waterfield MD, Kellie S. An sh3 domain and proline-rich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. J Biol Chem. 1994;269:13752-13755. (Pubitemid 24191115)
50. Mizuki K, Takeya R, Kuribayashi F, Nobuhisa I, Kohda D, Nunoi H, Takeshige K, Sumimoto H. A region c-terminal to the proline-rich core of p47phox regulates activation of the phagocyte NADPH oxidase by interacting with the c-terminal sh3 domain of p67phox. Arch Biochem Biophys. 2005;444:185-194. (Pubitemid 41728350)
51. Dusi S, Rossi F. Activation of NADPH oxidase of human neutrophils involves the phosphorylation and the translocation of cytosolic p67phox. Biochem J. 1993;296:367-371. (Pubitemid 23350838)
52. Benna JE, Dang PM, Gaudry M, Fay M, Morel F, Hakim J, Gougerot- Pocidalo MA. Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation: regulation by protein kinase c-dependent and independent pathways. J Biol Chem. 1997;272: 17204-17208. (Pubitemid 27289834)
53. Forbes LV, Truong O, Wientjes FB, Moss SJ, Segal AW. The major phosphorylation site of the NADPH oxidase component p67phox is thr233. Biochem J. 1999;338:99-105. (Pubitemid 29097291)
54. Dang PM, Morel F, Gougerot-Pocidalo MA, El Benna J. Phosphorylation of the NADPH oxidase component p67(phox) by erk2 and p38mapk: selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptide-rich region. Biochemistry. 2003;42: 4520-4526. (Pubitemid 36457620)
55. Zhao X, Xu B, Bhattacharjee A, Oldfield CM, Wientjes FB, Feldman GM, Cathcart MK. Protein kinase cdelta regulates p67phox phosphorylation in human monocytes. J Leukoc Biol. 2005;77:414-420. (Pubitemid 40289572)
56. Dang PM, Raad H, Derkawi RA, Boussetta T, Paclet MH, Belambri SA, Makni-Maalej K, Kroviarski Y, Morel F, Gougerot-Pocidalo MA, El-Benna J. The NADPH oxidase cytosolic component p67phox is constitutively phosphorylated in human neutrophils: regulation by a protein tyrosine kinase, mek1/2 and phosphatases 1/2a. Biochem Pharmacol. 2011;82:1145-1152.
57. Sancho-Shimizu V, Malo D. Sequencing, expression, and functional analyses support the candidacy of ncf2 in susceptibility to salmonella typhimurium infection in wild-derived mice. J Immunol. 2006;176: 6954-6961. (Pubitemid 43787876)
58. Ueyama T, Tatsuno T, Kawasaki T, Tsujibe S, Shirai Y, Sumimoto H, Leto TL, Saito N. A regulated adaptor function of p40phox: Distinct p67phox membrane targeting by p40phox and by p47phox. Mol Biol Cell. 2007;18:441-454. (Pubitemid 46213214)
59. Ago T, Takeya R, Hiroaki H, Kuribayashi F, Ito T, Kohda D, Sumimoto H. The px domain as a novel phosphoinositide-binding module. Biochem Biophys Res Commun. 2001;287:733-738. (Pubitemid 32912776)
60. Zhan Y, Virbasius JV, Song X, Pomerleau DP, Zhou GW. The p40phox and p47phox px domains of NADPH oxidase target cell membranes via direct and indirect recruitment by phosphoinositides. J Biol Chem. 2002;277:4512-4518. (Pubitemid 34968719)
61. Tian W, Li XJ, Stull ND, Ming W, Suh CI, Bissonnette SA, Yaffe MB, Grinstein S, Atkinson SJ, Dinauer MC. Fc gamma r-stimulated activation of the NADPH oxidase: Phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome. Blood. 2008;112:3867-3877.
62. Cross AR. P40(phox) participates in the activation of NADPH oxidase by increasing the affinity of p47(phox) for flavocytochrome b(558). Biochem J. 2000;349:113-117. (Pubitemid 30440172)
63. Ueyama T, Nakakita J, Nakamura T, Kobayashi T, Kobayashi T, Son J, Sakuma M, Sakaguchi H, Leto TL, Saito N. Cooperation of p40phox with p47phox for nox2 activation during fcγr-mediated phagocytosis: mechanism for acquisition of p40phox pi(3)p binding. J Biol Chem. 2011;286:40693-40705.
64. Dusi S, Donini M, Rossi F. Mechanisms of NADPH oxidase activation: Translocation of p40phox, rac1 and rac2 from the cytosol to the membranes in human neutrophils lacking p47phox or p67phox. Biochem J. 1996;314:409-412.
65. Ellson C, Davidson K, Anderson K, Stephens LR, Hawkins PT. Ptdins3p binding to the px domain of p40phox is a physiological signal in NADPH oxidase activation. EMBO J. 2006;25:4468-4478. (Pubitemid 44498121)
66. Bissonnette SA, Glazier CM, Stewart MQ, Brown GE, Ellson CD, Yaffe MB. Phosphatidylinositol 3-phosphate-dependent and -independent functions of p40phox in activation of the neutrophil NADPH oxidase. J Biol Chem. 2008;283:2108-2119.
67. Fan LM, Teng L, Li JM. Knockout of p47 phox uncovers a critical role of p40 phox in reactive oxygen species production in microvascular endothelial cells. Arterioscler Thromb Vasc Biol. 2009;29:1651-1656.
68. Suh CI, Stull ND, Li XJ, Tian W, Price MO, Grinstein S, Yaffe MB, Atkinson S, Dinauer MC. The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcgammaIIa receptorinduced phagocytosis. J Exp Med. 2006;203:1915-1925. (Pubitemid 44188466)
69. Chessa TA, Anderson KE, Hu Y, Xu Q, Rausch O, Stephens LR, Hawkins PT. Phosphorylation of threonine 154 in p40phox is an important physiological signal for activation of the neutrophil NADPH oxidase. Blood. 2010;116:6027-6036.
70. Bouin AP, Grandvaux N, Vignais PV, Fuchs A. P40(phox) is phosphorylated on threonine 154 and serine 315 during activation of the phagocyte NADPH oxidase: implication of a protein kinase c-type kinase in the phosphorylation process. J Biol Chem. 1998;273: 30097-30103. (Pubitemid 28545470)
71. Someya A, Nunoi H, Hasebe T, Nagaoka I. Phosphorylation of p40-phox during activation of neutrophil NADPH oxidase. J Leukoc Biol. 1999;66:851-857. (Pubitemid 29532049)
72. Lopes LR, Dagher MC, Gutierrez A, Young B, Bouin AP, Fuchs A, Babior BM. Phosphorylated p40phox as a negative regulator of NADPH oxidase. Biochemistry. 2004;43:3723-3730. (Pubitemid 38391727)
73. Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, Marchal CC, Stull ND, Lewis DB, Steele M, Kellner JD, Yu W, Meroueh SO, Nauseef WM, Dinauer MC. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114:3309-3315.
74. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, Gorlach A. Nox2 and nox4 mediate proliferative response in endothelial cells. Antioxidant Redox Signal. 2006;8:1473-1484. (Pubitemid 44726324)
75. Hahn NE, Meischl C, Wijnker PJ, Musters RJ, Fornerod M, Janssen HW, Paulus WJ, van Rossum AC, Niessen HW, Krijnen PA. Nox2, p22phox and p47phox are targeted to the nuclear pore complex in ischemic cardiomyocytes colocalizing with local reactive oxygen species. Cell Physiol Biochem. 2011;27:471-478.
76. Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E, Herrmann F, Hadengue A, Krause KH. Expression of nox1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol. 2005;207:164-176. (Pubitemid 41404147)
77. Hanna IR, Hilenski LL, Dikalova A, Taniyama Y, Dikalov S, Lyle A, Quinn MT, Lassegue B, Griendling KK. Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med. 2004;37:1542-1549. (Pubitemid 39349801)
78. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP. Direct interaction of the novel nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem. 2004;279:45935-45941. (Pubitemid 39491586)
79. Kawahara T, Ritsick D, Cheng G, Lambeth JD. Point mutations in the proline-rich region of p22phox are dominant inhibitors of nox1- and nox2-dependent reactive oxygen generation. J Biol Chem. 2005;280: 31859-31869. (Pubitemid 41291936)
80. Takeya R, Ueno N, Kami K, Taura M, Kohjima M, Izaki T, Nunoi H, Sumimoto H. Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem. 2003;278:25234-25246. (Pubitemid 37548688)
81. Banfi B, Clark RA, Steger K, Krause KH. Two novel proteins activate superoxide generation by the NADPH oxidase nox1. J Biol Chem. 2003;278:3510-3513. (Pubitemid 36801072)
82. Geiszt M, Lekstrom K, Witta J, Leto TL. Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem. 2003;278: 20006-20012. (Pubitemid 36799193)
83. Niu XL, Madamanchi NR, Vendrov AE, Tchivilev I, Rojas M, Madamanchi C, Brandes RP, Krause KH, Humphries J, Smith A, Burnand KG, Runge MS. Nox activator 1: A potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation. 2010;121:549-559.
84. Ambasta RK, Schreiber JG, Janiszewski M, Busse R, Brandes RP. Noxa1 is a central component of the smooth muscle NADPH oxidase in mice. Free Radic Biol Med. 2006;41:193-201. (Pubitemid 43928491)
85. Ali MI, Ketsawatsomkron P, Belin de Chantemele EJ, Mintz JD, Muta K, Salet C, Black SM, Tremblay ML, Fulton DJ, Marrero MB, Stepp DW. Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone. Circ Res. 2009;105:1013-1022.
86. Ago T, Kitazono T, Kuroda J, Kumai Y, Kamouchi M, Ooboshi H, Wakisaka M, Kawahara T, Rokutan K, Ibayashi S, Iida M. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke. 2005;36: 1040-1046. (Pubitemid 40629300)
87. Ueyama T, Geiszt M, Leto TL. Involvement of rac1 in activation of multicomponent nox1- and nox3-based NADPH oxidases. Mol Cell Biol. 2006;26:2160-2174. (Pubitemid 43346918)
88. Dutta S, Rittinger K. Regulation of noxo1 activity through reversible interactions with p22 and noxa1. PloS One. 2010;5:e10478.
89. Park HS, Park D, Bae YS. Molecular interaction of NADPH oxidase 1 with betapix and nox organizer 1. Biochem Biophys Res Commun. 2006;339:985-990. (Pubitemid 41772908)
90. Cheng G, Lambeth JD. Noxo1, regulation of lipid binding, localization, and activation of nox1 by the phox homology (px) domain. J Biol Chem. 2004;279:4737-4742. (Pubitemid 38199068)
91. Kiss PJ, Knisz J, Zhang Y, Baltrusaitis J, Sigmund CD, Thalmann R, Smith RJ, Verpy E, Banfi B. Inactivation of NADPH oxidase organizer 1 results in severe imbalance. Curr Biol. 2006;16:208-213. (Pubitemid 43117437)
92. Gianni D, DerMardirossian C, Bokoch GM. Direct interaction between tks proteins and the n-terminal proline-rich region (prr) of noxa1 mediates nox1-dependent ROS generation. Eur J Cell Biol. 2011;90: 164-171.
93. Kim JS, Diebold BA, Babior BM, Knaus UG, Bokoch GM. Regulation of nox1 activity via protein kinase a-mediated phosphorylation of noxa1 and 14-3-3 binding. J Biol Chem. 2007;282:34787-34800. (Pubitemid 350232473)
94. Oh H, Jung HY, Kim J, Bae YS. Phosphorylation of serine282 in NADPH oxidase activator 1 by erk desensitizes egf-induced ROS generation. Biochem Biophys Res Commun. 2010;394:691-696.
95. Kroviarski Y, Debbabi M, Bachoual R, Perianin A, Gougerot-Pocidalo MA, El-Benna J, Dang PM. Phosphorylation of NADPH oxidase activator 1 (noxa1) on serine 282 by map kinases and on serine 172 by protein kinase c and protein kinase a prevents nox1 hyperactivation. FASEB J. 2010;24:2077-2092.
96. Gianni D, Taulet N, DerMardirossian C, Bokoch GM. C-Src-mediated phosphorylation of noxa1 and tks4 induces the reactive oxygen species (ROS)-dependent formation of functional invadopodia in human colon cancer cells. Mol Biol Cell. 2010;21:4287-4298.
97. Flaherty JP, Spruce CA, Fairfield HE, Bergstrom DE. Generation of a conditional null allele of NADPH oxidase activator 1 (noxa1). Genesis. 2010;48:568-575.
98. Cheng G, Diebold BA, Hughes Y, Lambeth JD. Nox1-dependent reactive oxygen generation is regulated by rac1. J Biol Chem. 2006;281: 17718-17726. (Pubitemid 44035570)
99. Bokoch GM, Zhao T. Regulation of the phagocyte NADPH oxidase by rac gtpase. Antioxidant Redox Signal. 2006;8:1533-1548. (Pubitemid 44726329)
100. Park HS, Lee SH, Park D, Lee JS, Ryu SH, Lee WJ, Rhee SG, Bae YS. Sequential activation of phosphatidylinositol 3-kinase, beta pix, rac1, and nox1 in growth factor-induced production of h2o2. Mol Cell Biol. 2004;24:4384-4394. (Pubitemid 41071008)
101. Diebold BA, Fowler B, Lu J, Dinauer MC, Bokoch GM. Antagonistic cross-talk between rac and cdc42 gtpases regulates generation of reactive oxygen species. J Biol Chem. 2004;279:28136-28142. (Pubitemid 38900087)
102. Gianni D, Bohl B, Courtneidge SA, Bokoch GM. The involvement of the tyrosine kinase c-src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1. Mol Biol Cell. 2008;19: 2984-2994.
103. Helmcke I, Heumuller S, Tikkanen R, Schroder K, Brandes RP. Identification of structural elements in nox1 and nox4 controlling localization and activity. Antioxidant Redox Signal. 2009;11:1279-1287.
104. Chen F, Pandey D, Chadli A, Catravas JD, Chen T, Fulton DJ. Hsp90 regulates NADPH oxidase activity and is necessary for superoxide but not hydrogen peroxide production. Antioxidant Redox Signal. 2011;14: 2107-2119.
105. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of nox1 and nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24:677-683. (Pubitemid 38451603)
106. Miller FJ Jr, Filali M, Huss GJ, Stanic B, Chamseddine A, Barna TJ, Lamb FS. Cytokine activation of nuclear factor kappa b in vascular smooth muscle cells requires signaling endosomes containing nox1 and clc-3. Circ Res. 2007;101:663-671. (Pubitemid 47494097)
107. Zhang G, Zhang F, Muh R, Yi F, Chalupsky K, Cai H, Li PL. Autocrine/ paracrine pattern of superoxide production through NAD(P)H oxidase in coronary arterial myocytes. Am J Physiol Heart Circ Physiol. 2007;292: H483-H495. (Pubitemid 46105211)
108. Miller FJ Jr, Chu X, Stanic B, Tian X, Sharma RV, Davisson RL, Lamb FS. A differential role for endocytosis in receptor-mediated activation of nox1. Antioxidant Redox Signal. 2010;12:583-593.
109. Chu X, Filali M, Stanic B, Takapoo M, Sheehan A, Bhalla R, Lamb FS, Miller FJ Jr. A critical role for chloride channel-3 (cic-3) in smooth muscle cell activation and neointima formation. Arterioscler Thromb Vasc Biol. 2011;31:345-351.
110. Janiszewski M, Lopes LR, Carmo AO, Pedro MA, Brandes RP, Santos CX, Laurindo FR. Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem. 2005;280:40813-40819. (Pubitemid 41780573)
111. Fernandes DC, Manoel AH, Wosniak J Jr, Laurindo FR. Protein disulfide isomerase overexpression in vascular smooth muscle cells induces spontaneous preemptive NADPH oxidase activation and nox1 mRNA expression: effects of nitrosothiol exposure. Arch Biochem Biophys. 2009;484:197-204.
112. Geiszt M, Kopp JB, Varnai P, Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A. 2000;97: 8010-8014. (Pubitemid 30460764)
113. Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, Sumimoto H. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem. 2001;276:1417-1423. (Pubitemid 32096573)
114. Lee CF, Qiao M, Schroder K, Zhao Q, Asmis R. Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized low density lipoprotein-induced macrophage death. Circ Res. 2010;106:1489-1497.
115. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG. Functional analysis of nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal. 2006;18:69-82. (Pubitemid 41415716)
116. Djordjevic T, BelAiba RS, Bonello S, Pfeilschifter J, Hess J, Gorlach A. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler Thromb Vasc Biol. 2005;25:519-525. (Pubitemid 40315672)
117. von Lohneysen K, Noack D, Wood MR, Friedman JS, Knaus UG. Structural insights into nox4 and nox2: motifs involved in function and cellular localization. Mol Cell Biol. 2010;30:961-975.
118. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Forro L, Schlegel W, Krause KH. Nox4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J. 2007;406:105-114. (Pubitemid 47264740)
119. Nisimoto Y, Jackson HM, Ogawa H, Kawahara T, Lambeth JD. Constitutive NADPH-dependent electron transferase activity of the nox4 dehydrogenase domain. Biochemistry. 2010;49:2433-2442.
120. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassegue B, Griendling KK. Poldip2, a novel regulator of nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res. 2009;105:249-259.
121. von Lohneysen K, Noack D, Jesaitis AJ, Dinauer MC, Knaus UG. Mutational analysis reveals distinct features of the nox4-p22 phox complex. J Biol Chem. 2008;283:35273-35282.
122. Anilkumar N, Weber R, Zhang M, Brewer A, Shah AM. Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler Thromb Vasc Biol. 2008;28: 1347-1354.
123. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, Abboud HE. Nox4 mediates angiotensin II-induced activation of akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol. 2003;285: F219-F229. (Pubitemid 36871194)
124. Wu RF, Ma Z, Myers DP, Terada LS. HIV-1 tat activates dual nox pathways leading to independent activation of erk and jnk map kinases. J Biol Chem. 2007;282:37412-37419.
125. Lee S, Gharavi NM, Honda H, Chang I, Kim B, Jen N, Li R, Zimman A, Berliner JA. A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids. Free Radic Biol Med. 2009;47:145-151.
126. Zhuang J, Jiang T, Lu D, Luo Y, Zheng C, Feng J, Yang D, Chen C, Yan X. NADPH oxidase 4 mediates reactive oxygen species induction of cd146 dimerization in VEGF signal transduction. Free Radic Biol Med. 2010;49:227-236.
127. Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS. Cutting edge: direct interaction of tlr4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 2004;173:3589-3593. (Pubitemid 39280716)
128. Mahadev K, Motoshima H, Wu X, Ruddy JM, Arnold RS, Cheng G, Lambeth JD, Goldstein BJ. The NAD(P)H oxidase homolog nox4 modulates insulin-stimulated generation of h2o2 and plays an integral role in insulin signal transduction. Mol Cell Biol. 2004;24:1844-1854. (Pubitemid 38248927)
129. Kuroda J, Nakagawa K, Yamasaki T, Nakamura K, Takeya R, Kuribayashi F, Imajoh-Ohmi S, Igarashi K, Shibata Y, Sueishi K, Sumimoto H. The superoxide-producing NAD(P)H oxidase nox4 in the nucleus of human vascular endothelial cells. Genes Cells. 2005;10:1139-1151. (Pubitemid 41830073)
130. Hu T, Ramachandrarao SP, Siva S, Valancius C, Zhu Y, Mahadev K, Toh I, Goldstein BJ, Woolkalis M, Sharma K. Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells. Am J Physiol Renal Physiol. 2005;289:F816-F825. (Pubitemid 41324203)
131. Park HS, Chun JN, Jung HY, Choi C, Bae YS. Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. Cardiovasc Res. 2006;72:447-455. (Pubitemid 44665857)
132. Grange L, Nguyen MV, Lardy B, Derouazi M, Campion Y, Trocme C, Paclet MH, Gaudin P, Morel F. NAD(P)H oxidase activity of nox4 in chondrocytes is both inducible and involved in collagenase expression. Antioxidant Redox Signal. 2006;8:1485-1496. (Pubitemid 44726325)
133. Basuroy S, Tcheranova D, Bhattacharya S, Leffler CW, Parfenova H. Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-alpha-induced apoptosis. Am J Physiol Cell Physiol. 2011;300: C256-C265.
134. New D, Block K, Bhandari B, Gorin YC, Abboud HE. Igf-1 increases the expression of fibronectin by nox4-dependent akt phosphorylation in renal tubular epithelial cells. Am J Physiol Cell Physiol. 2011;302: C122-C130.
135. Bondi CD, Manickam N, Lee DY, Block K, Gorin Y, Abboud HE, Barnes JL. NAD(P)H oxidase mediates tgf-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol. 2010;21:93-102.
136. Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, Ahmad M, Edwards J, Wolin MS. Cytosolic NADPH may regulate differences in basal nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol. 2005;288: H13-H21. (Pubitemid 40023822)
137. Spencer NY, Yan Z, Boudreau RL, Zhang Y, Luo M, Li Q, Tian X, Shah AM, Davisson RL, Davidson B, Banfi B, Engelhardt JF. Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4. J Biol Chem. 2011;286:8977-8987.
138. Ben Mkaddem S, Pedruzzi E, Werts C, Coant N, Bens M, Cluzeaud F, Goujon JM, Ogier-Denis E, Vandewalle A. Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury. Cell Death Differentiation. 2010;17:1474-1485.
139. Ago T, Kuroda J, Pain J, Fu C, Li H, Sadoshima J. Upregulation of nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res. 2010;106:1253-1264.
140. Goyal P, Weissmann N, Rose F, Grimminger F, Schafers HJ, Seeger W, Hanze J. Identification of novel nox4 splice variants with impact on ROS levels in a549 cells. Biochem Biophys Res Commun. 2005;329: 32-39. (Pubitemid 40255416)
141. Jackson HM, Kawahara T, Nisimoto Y, Smith SM, Lambeth JD. Nox4 b-loop creates an interface between the transmembrane and dehydrogenase domains. J Biol Chem. 2010;285:10281-10290.
142. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK. Distinct roles of nox1 and nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med. 2008;45:1340-1351.
143. Takac I, Schroder K, Zhang L, Lardy B, Anilkumar N, Lambeth JD, Shah AM, Morel F, Brandes RP. The e-loop is involved in hydrogen peroxide formation by the NADPH oxidase nox4. J Biol Chem. 2011; 286:13304-13313.
144. Zhang L, Nguyen MV, Lardy B, Jesaitis AJ, Grichine A, Rousset F, Talbot M, Paclet MH, Qian G, Morel F. New insight into the nox4 subcellular localization in hek293 cells: first monoclonal antibodies against nox4. Biochimie. 2011;93:457-468.
145. Yoshida LS, Tsunawaki S. Expression of NADPH oxidases and enhanced h(2)o(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha. Int Immunopharmacol. 2008;8:1377-1385.
146. Banfi B, Molnar G, Maturana A, Steger K, Hegedus B, Demaurex N, Krause KH. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem. 2001;276:37594-37601.
147. 2+ activation of the NADPH oxidase 5 (nox5). J Biol Chem. 2004;279:18583-18591. (Pubitemid 38623279)
148. Fu X, Beer DG, Behar J, Wands J, Lambeth D, Cao W. Camp-response element-binding protein mediates acid-induced NADPH oxidase nox5-s expression in Barrett esophageal adenocarcinoma cells. J Biol Chem. 2006;281:20368-20382. (Pubitemid 44065811)
149. Si J, Fu X, Behar J, Wands J, Beer DG, Souza RF, Spechler SJ, Lambeth D, Cao W. NADPH oxidase nox5-s mediates acid-induced cyclooxygenase- 2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells. J Biol Chem. 2007;282: 16244-16255. (Pubitemid 47100387)
150. BelAiba RS, Djordjevic T, Petry A, Diemer K, Bonello S, Banfi B, Hess J, Pogrebniak A, Bickel C, Gorlach A. Nox5 variants are functionally active in endothelial cells. Free Radic Biol Med. 2007;42:446-459. (Pubitemid 46162114)
151. Kawahara T, Jackson HM, Smith SM, Simpson PD, Lambeth JD. Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain. Biochemistry. 2011;50:2013-2025.
152. Hong J, Resnick M, Behar J, Wands J, DeLellis RA, Cao W. Role of rac1 in regulation of nox5-s function in Barrett's esophageal adenocarcinoma cells. Am J Physiol Cell Physiol. 2011;301:C413-C420.
153. Montezano AC, Burger D, Paravicini TM, Chignalia AZ, Yusuf H, Almasri M, He Y, Callera GE, He G, Krause KH, Lambeth D, Quinn MT, Touyz RM. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells. Circ Res. 2010;106:1363-1373.
154. Jay DB, Papaharalambus CA, Seidel-Rogol B, Dikalova AE, Lassegue B, Griendling KK. Nox5 mediates pdgf-induced proliferation in human aortic smooth muscle cells. Free Radic Biol Med. 2008;45:329-335.
155. Serrander L, Jaquet V, Bedard K, Plastre O, Hartley O, Arnaudeau S, Demaurex N, Schlegel W, Krause KH. Nox5 is expressed at the plasma membrane and generates superoxide in response to protein kinase c activation. Biochimie. 2007;89:1159-1167. (Pubitemid 47248008)
156. Tirone F, Radu L, Craescu CT, Cox JA. Identification of the binding site for the regulatory calcium-binding domain in the catalytic domain of nox5. Biochemistry. 2010;49:761-771.
157. Tirone F, Cox JA. NADPH oxidase 5 (nox5) interacts with and is regulated by calmodulin. FEBS Lett. 2007;581:1202-1208. (Pubitemid 46385949)
158. Jagnandan D, Church JE, Banfi B, Stuehr DJ, Marrero MB, Fulton DJ. Novel mechanism of activation of NADPH oxidase 5. Calcium sensitization via phosphorylation. J Biol Chem. 2007;282:6494-6507. (Pubitemid 47100887)
159. Pandey D, Gratton JP, Rafikov R, Black SM, Fulton DJ. Calcium/calmodulin- dependent kinase ii mediates the phosphorylation and activation of NADPH oxidase 5. Mol Pharmacol. 2011;80:407-415.
160. El Jamali A, Valente AJ, Lechleiter JD, Gamez MJ, Pearson DW, Nauseef WM, Clark RA. Novel redox-dependent regulation of nox5 by the tyrosine kinase c-abl. Free Radic Biol Med. 2008;44:868-881.
161. Zhou X, Li D, Resnick MB, Behar J, Wands J, Cao W. Signaling in h2o2-induced increase in cell proliferation in Barrett's esophageal adenocarcinoma cells. J Pharmacol Exp Ther. 2011;339:218-227.
162. Kawahara T, Lambeth JD. Phosphatidylinositol (4,5)-bisphosphate modulates nox5 localization via an n-terminal polybasic region. Mol Biol Cell. 2008;19:4020-4031.
163. Taylor RM, Burritt JB, Baniulis D, Foubert TR, Lord CI, Dinauer MC, Parkos CA, Jesaitis AJ. Site-specific inhibitors of NADPH oxidase activity and structural probes of flavocytochrome B: characterization of six monoclonal antibodies to the p22phox subunit. J Immunol. 2004; 173:7349-7357. (Pubitemid 39628173)
164. Zhu Y, Marchal CC, Casbon AJ, Stull N, von Lohneysen K, Knaus UG, Jesaitis AJ, McCormick S, Nauseef WM, Dinauer MC. Deletion mutagenesis of p22phox subunit of flavocytochrome b558: identification of regions critical for gp91phox maturation and NADPH oxidase activity. J Biol Chem. 2006;281:30336-30346. (Pubitemid 44582087)
165. Biberstine-Kinkade KJ, Yu L, Stull N, LeRoy B, Bennett S, Cross A, Dinauer MC. Mutagenesis of p22(phox) histidine 94 A histidine in this position is not required for flavocytochrome b558 function. J Biol Chem. 2002;277:30368-30374.
166. Porter CD, Parkar MH, Verhoeven AJ, Levinsky RJ, Collins MK, Kinnon C. P22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox. Blood. 1994;84:2767-2775. (Pubitemid 24317411)
167. Nakano Y, Longo-Guess CM, Bergstrom DE, Nauseef WM, Jones SM, Banfi B. Mutation of the cyba gene encoding p22phox causes vestibular and immune defects in mice. J Clin Invest. 2008;118:1176-1185. (Pubitemid 351364624)
168. Lewis EM, Sergeant S, Ledford B, Stull N, Dinauer MC, McPhail LC. Phosphorylation of p22phox on threonine 147 enhances NADPH oxidase activity by promoting p47phox binding. J Biol Chem. 2010;285: 2959-2967.
169. Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, Lyons E, Krause KH, Banfi B, Lambeth JD, Lassegue B, Griendling KK. Mechanisms of vascular smooth muscle NADPH oxidase 1 (nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol. 2009;29:480-487.
170. Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, Krause KH. Decreased blood pressure in nox1-deficient mice. FEBS Lett. 2006;580:497-504. (Pubitemid 43089678)
171. San Martin A, Foncea R, Laurindo FR, Ebensperger R, Griendling KK, Leighton F. Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products. Free Radic Biol Med. 2007;42:1671-1679. (Pubitemid 46617146)
172. Wendt MC, Daiber A, Kleschyov AL, Mulsch A, Sydow K, Schulz E, Chen K, Keaney JF Jr, Lassegue B, Walter U, Griendling KK, Munzel T. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med. 2005;39:381-391. (Pubitemid 40910195)
173. San Martin A, Du P, Dikalova A, Lassegue B, Aleman M, Gongora MC, Brown K, Joseph G, Harrison DG, Taylor WR, Jo H, Griendling KK. Reactive oxygen species-selective regulation of aortic inflammatory gene expression in type 2 diabetes. Am J Physiol Heart Circ Physiol. 2007;292:H2073-H2082. (Pubitemid 47084581)
174. Castier Y, Brandes RP, Leseche G, Tedgui A, Lehoux S. P47phoxdependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res. 2005;97:533-540. (Pubitemid 41361743)
175. Garrido-Urbani S, Jemelin S, Deffert C, Carnesecchi S, Basset O, Szyndralewiez C, Heitz F, Page P, Montet X, Michalik L, Arbiser J, Ruegg C, Krause KH, Imhof BA. Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a pparalpha mediated mechanism. PLoS One. 2011;6:e14665.
176. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88: 888-894. (Pubitemid 32441466)
177. Wang X, Sun Z. Thyroid hormone induces artery smooth muscle cell proliferation: discovery of a new tralpha1-nox1 pathway. J Cell Mol Med. 2010;14:368-380.
178. Menshikov M, Plekhanova O, Cai H, Chalupsky K, Parfyonova Y, Bashtrikov P, Tkachuk V, Berk BC. Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redoxdependent pathways. Arterioscler Thromb Vasc Biol. 2006;26:801-807. (Pubitemid 43732154)
179. Katsuyama M, Fan C, Yabe-Nishimura C. NADPH oxidase is involved in prostaglandin f2alpha-induced hypertrophy of vascular smooth muscle cells: Induction of nox1 by pgf2alpha. J Biol Chem. 2002;277: 13438-13442. (Pubitemid 34967938)
180. Yin CC, Huang KT. H2O2 but not O2- elevated by oxidized LDL enhances human aortic smooth muscle cell proliferation. J Biomed Sci. 2007;14:245-254.
181. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. Cell transformation by the superoxidegenerating oxidase mox1. Nature. 1999;401:79-82.
182. Stanic B, Katsuyama M, Miller FJ Jr. An oxidized extracellular oxidation-reduction state increases nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation. Arterioscler Thromb Vasc Biol. 2010;30:2234-2241.
183. Dammanahalli JK, Sun Z. Endothelin (ET)-1 inhibits nicotinamide adenine dinucleotide phosphate oxidase activity in human abdominal aortic endothelial cells: A novel function of etb1 receptors. Endocrinology. 2008;149:4979-4987.
184. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. P38map kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II: role in vascular smooth muscle cell hypertrophy. J Biol Chem. 1998;273:15022-15029. (Pubitemid 28272796)
185. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of akt/ protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem. 1999;274:22699-22704.
186. Ranjan P, Anathy V, Burch PM, Weirather K, Lambeth JD, Heintz NH. Redox-dependent expression of cyclin d1 and cell proliferation by nox1 in mouse lung epithelial cells. Antioxidant Redox Signal. 2006;8: 1447-1459.
187. Sancho P, Bertran E, Caja L, Carmona-Cuenca I, Murillo MM, Fabregat I. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms. Biochim Biophys Acta. 2009;1793:253-263.
188. Kim YS, Morgan MJ, Choksi S, Liu ZG. Tnf-induced activation of the nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell. 2007;26:675-687. (Pubitemid 46856240)
189. Schilder YD, Heiss EH, Schachner D, Ziegler J, Reznicek G, Sorescu D, Dirsch VM. NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radic Biol Med. 2009;46:1598-1606.
190. Zimmerman MC, Takapoo M, Jagadeesha DK, Stanic B, Banfi B, Bhalla RC, Miller FJ Jr. Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells. Hypertension. 2011;58: 446-453.
191. Schroder K, Helmcke I, Palfi K, Krause KH, Busse R, Brandes RP. Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2007;27: 1736-1743. (Pubitemid 47207168)
192. Maheswaranathan M, Gole HK, Fernandez I, Lassegue B, Griendling KK, San Martin A. Platelet-derived growth factor (PDGF) regulates slingshot phosphatase activity via nox1-dependent auto-dephosphorylation of serine 834 in vascular smooth muscle cells. J Biol Chem. 2011;286:35430-35437.
193. San Martin A, Lee MY, Williams HC, Mizuno K, Lassegue B, Griendling KK. Dual regulation of cofilin activity by lim kinase and slingshot-1l phosphatase controls platelet-derived growth factor-induced migration of human aortic smooth muscle cells. Circ Res. 2008;102: 432-438. (Pubitemid 351651101)
194. Shinohara M, Adachi Y, Mitsushita J, Kuwabara M, Nagasawa A, Harada S, Furuta S, Zhang Y, Seheli K, Miyazaki H, Kamata T. Reactive oxygen generated by NADPH oxidase 1 (nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration. J Biol Chem. 2010;285:4481-4488.
195. Haloui M, Meilhac O, Jandrot-Perrus M, Michel JB. Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin. Eur J Pharmacol. 2003;474:175-184. (Pubitemid 37281446)
196. Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, Koller A. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2003;23:418-424. (Pubitemid 36337217)
197. Lee JG, Lim EJ, Park DW, Lee SH, Kim JR, Baek SH. A combination of lox-1 and nox1 regulates tlr9-mediated foam cell formation. Cell Signal. 2008;20:2266-2275.
198. Duerrschmidt N, Stielow C, Muller G, Pagano PJ, Morawietz H. NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells. J Physiol. 2006;576:557-567. (Pubitemid 44490145)
199. Furst R, Brueckl C, Kuebler WM, Zahler S, Krotz F, Gorlach A, Vollmar AM, Kiemer AK. Atrial natriuretic peptide induces mitogenactivated protein kinase phosphatase-1 in human endothelial cells via rac1 and NAD(P)H oxidase/nox2-activation. Circ Res. 2005;96:43-53. (Pubitemid 40095753)
200. Li H, Hortmann M, Daiber A, Oelze M, Ostad MA, Schwarz PM, Xu H, Xia N, Kleschyov AL, Mang C, Warnholtz A, Munzel T, Forstermann U. Cyclooxygenase 2-selective and nonselective nonsteroidal antiinflammatory drugs induce oxidative stress by up-regulating vascular NADPH oxidases. J Pharmacol Exp Ther. 2008;326:745-753.
201. Schuhmacher S, Foretz M, Knorr M, Jansen T, Hortmann M, Wenzel P, Oelze M, Kleschyov AL, Daiber A, Keaney JF Jr, Wegener G, Lackner K, Munzel T, Viollet B, Schulz E. Alpha1amp-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting nox2 upregulation. Arterioscler Thromb Vasc Biol. 2011;31: 560-566.
202. Thakur S, Du J, Hourani S, Ledent C, Li JM. Inactivation of adenosine a2a receptor attenuates basal and angiotensin II-induced ros production by nox2 in endothelial cells. J Biol Chem. 2010;285:40104-40113.
203. Takenouchi Y, Kobayashi T, Matsumoto T, Kamata K. Gender differences in age-related endothelial function in the murine aorta. Atherosclerosis. 2009;206:397-404.
204. Zemse SM, Hilgers RH, Webb RC. Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ang II in murine aortic rings. Am J Physiol Heart Circ Physiol. 2007;292:H3103-H3108. (Pubitemid 47084565)
205. Violi F, Sanguigni V, Carnevale R, et al. Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation. 2009;120:1616-1622.
206. Taye A, Saad AH, Kumar AH, Morawietz H. Effect of apocynin on NADPH oxidase-mediated oxidative stress-lox-1-eNOS pathway in human endothelial cells exposed to high glucose. Eur J Pharmacol. 2010;627:42-48.
207. Hwang J, Saha A, Boo YC, Sorescu GP, McNally JS, Holland SM, Dikalov S, Giddens DP, Griendling KK, Harrison DG, Jo H. Oscillatory shear stress stimulates endothelial production of O2- from p47phoxdependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem. 2003;278:47291-47298. (Pubitemid 37452318)
208. Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:23-28. (Pubitemid 38082407)
209. Pietrowski E, Bender B, Huppert J, White R, Luhmann HJ, Kuhlmann CR. Pro-inflammatory effects of interleukin-17a on vascular smooth muscle cells involve NAD(P)H- oxidase derived reactive oxygen species. J Vasc Res. 2011;48:52-58.
210. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol. 2003;285:H2290-H2297. (Pubitemid 37443044)
211. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111:1201-1209. (Pubitemid 36519937)
212. Weaver M, Liu J, Pimentel D, Reddy DJ, Harding P, Peterson EL, Pagano PJ. Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery. Am J Physiol Heart Circ Physiol. 2006;290:H1933-H1941.
213. Peshavariya H, Dusting GJ, Jiang F, Halmos LR, Sobey CG, Drummond GR, Selemidis S. NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedebergs Arch Pharmacol. 2009;380:193-204.
214. Li JM, Fan LM, George VT, Brooks G. Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53. Free Radic Biol Med. 2007;43:976-986. (Pubitemid 47241205)
215. Imanishi T, Kobayashi K, Kuroi A, Ikejima H, Akasaka T. Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell. Hypertens Res. 2008;31:757-765. (Pubitemid 351772867)
216. Ikeda S, Yamaoka-Tojo M, Hilenski L, Patrushev NA, Anwar GM, Quinn MT, Ushio-Fukai M. Iqgap1 regulates reactive oxygen speciesdependent endothelial cell migration through interacting with nox2. Arterioscler Thromb Vasc Biol 2005;25:2295-2300. (Pubitemid 41552645)
217. Pendyala S, Gorshkova IA, Usatyuk PV, He D, Pennathur A, Lambeth JD, Thannickal VJ, Natarajan V. Role of nox4 and nox2 in hyperoxiainduced reactive oxygen species generation and migration of human lung endothelial cells. Antioxidant Redox Signal. 2009;11:747-764.
218. Kim SY, Lee JG, Cho WS, Cho KH, Sakong J, Kim JR, Chin BR, Baek SH. Role of NADPH oxidase-2 in lipopolysaccharide-induced matrix metalloproteinase expression and cell migration. Immunol Cell Biol. 2010;88:197-204.
219. Schroder K, Kohnen A, Aicher A, Liehn EA, Buchse T, Stein S, Weber C, Dimmeler S, Brandes RP. NADPH oxidase nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells. Circ Res. 2009;105:537-544.
220. Looi YH, Grieve DJ, Siva A, Walker SJ, Anilkumar N, Cave AC, Marber M, Monaghan MJ, Shah AM. Involvement of nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension. 2008;51:319-325. (Pubitemid 351159945)
221. Wang M, Zhang J, Walker SJ, Dworakowski R, Lakatta EG, Shah AM. Involvement of NADPH oxidase in age-associated cardiac remodeling. J Mol Cell Cardiol. 2010;48:765-772.
222. Hingtgen SD, Tian X, Yang J, Dunlay SM, Peek AS, Wu Y, Sharma RV, Engelhardt JF, Davisson RL. Nox2-containing NADPH oxidase and akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genome. 2006;26:180-191.
223. Shanmugam P, Valente AJ, Prabhu SD, Venkatesan B, Yoshida T, Delafontaine P, Chandrasekar B. Angiotensin-II type 1 receptor and nox2 mediate tcf/lef and creb dependent wisp1 induction and cardiomyocyte hypertrophy. J Mol Cell Cardiol. 2011;50:928-938.
224. Stas S, Whaley-Connell A, Habibi J, Appesh L, Hayden MR, Karuparthi PR, Qazi M, Morris EM, Cooper SA, Link CD, Stump C, Hay M, Ferrario C, Sowers JR. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling. Endocrinology. 2007;148:3773-3780. (Pubitemid 47105865)
225. Wilson P, Morgan J, Funder JW, Fuller PJ, Young MJ. Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart. Clin Sci. 2009;116:731-739.
226. Nakamura T, Kataoka K, Fukuda M, Nako H, Tokutomi Y, Dong YF, Ichijo H, Ogawa H, Kim-Mitsuyama S. Critical role of apoptosis signalregulating kinase 1 in aldosterone/salt-induced cardiac inflammation and fibrosis. Hypertension. 2009;54:544-551.
227. Guzik TJ, Sadowski J, Kapelak B, Jopek A, Rudzinski P, Pillai R, Korbut R, Channon KM. Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol. 2004;24:1614-1620. (Pubitemid 39180884)
228. Miller AA, Drummond GR, Schmidt HH, Sobey CG. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res. 2005;97:1055-1062. (Pubitemid 41668919)
229. Clempus RE, Sorescu D, Dikalova AE, Pounkova L, Jo P, Sorescu GP, Schmidt HH, Lassegue B, Griendling KK. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2007;27:42-48. (Pubitemid 46360379)
230. Ellmark SH, Dusting GJ, Fui MN, Guzzo-Pernell N, Drummond GR. The contribution of nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res. 2005;65:495-504. (Pubitemid 40082491)
231. Goettsch C, Goettsch W, Arsov A, Hofbauer LC, Bornstein SR, Morawietz H. Long-term cyclic strain downregulates endothelial nox4. Antioxid Redox Signal 2009;11:2385-2397.
232. Hwang J, Ing MH, Salazar A, Lassegue B, Griendling K, Navab M, Sevanian A, Hsiai TK. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ Res. 2003;93:1225-1232. (Pubitemid 37543063)
233. Peshavariya H, Jiang F, Taylor CJ, Selemidis S, Chang CW, Dusting G. Translation-linked mRNA destabilization accompanying serum-induced nox4 expression in human endothelial cells. Antioxidant Redox Signal. 2009;11:2399-2408.
234. Haurani MJ, Cifuentes ME, Shepard AD, Pagano PJ. Nox4 oxidase overexpression specifically decreases endogenous nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration. Hypertension. 2008;52:143-149.
235. Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, Karwande SV, Stringham JC, Bull DA, Gleich M, Kennedy TP, Hoidal JR. Transforming growth factor-beta1 induces nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2006;290:L661-L673. (Pubitemid 43725071)
236. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factorbeta1- induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res. 2005;97:900-907. (Pubitemid 41552675)
237. Martin-Garrido A, Brown DI, Lyle AN, Dikalova A, Seidel-Rogol B, Lassegue B, San Martin A, Griendling KK. NADPH oxidase 4 mediates tgf-beta-induced smooth muscle alpha-actin via p38mapk and serum response factor. Free Radic Biol Med. 2011;50:354-362.
238. Ismail S, Sturrock A, Wu P, Cahill B, Norman K, Huecksteadt T, Sanders K, Kennedy T, Hoidal J. Nox4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: The role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. Am J Physiol Lung Cell Mol Physiol. 2009;296:L489-L499.
239. Amara N, Goven D, Prost F, Muloway R, Crestani B, Boczkowski J. Nox4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates tgfbeta1- induced fibroblast differentiation into myofibroblasts. Thorax. 2010;65: 733-738.
240. Yang S, Zhang Y, Ries W, Key L. Expression of nox4 in osteoclasts. J Cell Biochem. 2004;92:238-248.
241. Li J, Stouffs M, Serrander L, Banfi B, Bettiol E, Charnay Y, Steger K, Krause KH, Jaconi ME. The NADPH oxidase nox4 drives cardiac differentiation: role in regulating cardiac transcription factors and map kinase activation. Mol Biol Cell. 2006;17:3978-3988. (Pubitemid 44330881)
242. Pedruzzi E, Guichard C, Ollivier V, Driss F, Fay M, Prunet C, Marie JC, Pouzet C, Samadi M, Elbim C, O'Dowd Y, Bens M, Vandewalle A, Gougerot-Pocidalo MA, Lizard G, Ogier-Denis E. NAD(P)H oxidase nox-4 mediates 7-ketocholesterol- induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol. 2004;24:10703-10717. (Pubitemid 39603128)
243. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem. 2005;280: 39616-39626. (Pubitemid 41713921)
244. Lee YM, Kim BJ, Chun YS, So I, Choi H, Kim MS, Park JW. Nox4 as an oxygen sensor to regulate task-1 activity. Cell Signal. 2006;18: 499-507. (Pubitemid 41790370)
245. 2+ release channel by NADPH oxidase 4. Proc Natl Acad Sci U S A. 2011;108:16098-16103.
246. Szocs K, Lassegue B, Sorescu D, Hilenski LL, Valppu L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD, Griendling KK. Upregulation of nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol. 2002;22:21-27. (Pubitemid 34076227)
247. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation. 2002;105:1429-1435. (Pubitemid 34263273)
248. Perrotta I, Sciangula A, Perrotta E, Donato G, Cassese M. Ultrastructural analysis and electron microscopic localization of nox4 in healthy and atherosclerotic human aorta. Ultrastruct Pathol. 2011;35:1-6.
249. Guo SJ, Wu LY, Shen WL, Chen WD, Wei J, Gao PJ, Zhu DL. Gene profile for differentiation of vascular adventitial myofibroblasts. Sheng li xue bao: [Acta physiologica Sinica]. 2006;58:337-344.
250. Mouche S, Mkaddem SB, Wang W, Katic M, Tseng YH, Carnesecchi S, Steger K, Foti M, Meier CA, Muzzin P, Kahn CR, Ogier-Denis E, Szanto I. Reduced expression of the NADPH oxidase nox4 is a hallmark of adipocyte differentiation. Biochim Biophys Acta. 2007;1773: 1015-1027. (Pubitemid 46898667)
251. Xiao Q, Luo Z, Pepe AE, Margariti A, Zeng L, Xu Q. Embryonic stem cell differentiation into smooth muscle cells is mediated by nox4- produced h2o2. Am J Physiol Cell Physiol. 2009;296:C711-C723.
252. Datla SR, Peshavariya H, Dusting GJ, Mahadev K, Goldstein BJ, Jiang F. Important role of nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro. Arterioscler Thromb Vasc Biol. 2007;27:2319-2324. (Pubitemid 350203945)
253. Tong X, Hou X, Jourd'heuil D, Weisbrod RM, Cohen RA. Upregulation of nox4 by TGFβ1 oxidizes serca and inhibits no in arterial smooth muscle of the prediabetic Zucker rat. Circ Res. 2010;107:975-983.
254. Craige SM, Chen K, Pei Y, Li C, Huang X, Chen C, Shibata R, Sato K, Walsh K, Keaney JF Jr. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation. 2011;124:731-740.
255. Chen K, Kirber MT, Xiao H, Yang Y, Keaney JF Jr. Regulation of ros signal transduction by NADPH oxidase 4 localization. J Cell Biol. 2008;181:1129-1139. (Pubitemid 351915488)
256. Li S, Tabar SS, Malec V, Eul BG, Klepetko W, Weissmann N, Grimminger F, Seeger W, Rose F, Hanze J. Nox4 regulates ros levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Antioxidant Redox Signal. 2008;10:1687-1698.
257. Basuroy S, Bhattacharya S, Leffler CW, Parfenova H. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by tnf-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol. 2009; 296:C422-C432.
258. Tian XY, Yung LH, Wong WT, Liu J, Leung FP, Liu L, Chen Y, Kong SK, Kwan KM, Ng SM, Lai PB, Yung LM, Yao X, Huang Y. Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38mapk and jnk pathway. J Mol Cell Cardiol. 2012;52:237-244.
259. Senturk S, Mumcuoglu M, Gursoy-Yuzugullu O, Cingoz B, Akcali KC, Ozturk M. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology. 2010;52:966-974.
260. Weyemi U, Lagente-Chevallier O, Boufraqech M, Prenois F, Courtin F, Caillou B, Talbot M, Dardalhon M, Al Ghuzlan A, Bidart JM, Schlumberger M, Dupuy C. ROS-generating NADPH oxidase nox4 is a critical mediator in oncogenic h-ras-induced DNA damage and subsequent senescence. Oncogene. 2012;31:1117-1229.
261. Gomes P, Simao S, Silva E, Pinto V, Amaral JS, Afonso J, Serrao MP, Pinho MJ, Soares-da-Silva P. Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure. Oxid Med Cell Longev. 2009;2:138-145.
262. Li L, Smith A, Hagen TM, Frei B. Vascular oxidative stress and inflammation increase with age: Ameliorating effects of alpha-lipoic acid supplementation. Ann N Y Acad Sci. 2010;1203:151-159.
263. McCrann DJ, Yang D, Chen H, Carroll S, Ravid K. Upregulation of nox4 in the aging vasculature and its association with smooth muscle cell polyploidy. Cell Cycle. 2009;8:902-908.
264. Lener B, Koziel R, Pircher H, Hutter E, Greussing R, Herndler- Brandstetter D, Hermann M, Unterluggauer H, Jansen-Durr P. The NADPH oxidase nox4 restricts the replicative lifespan of human endothelial cells. Biochem J. 2009;423:363-374.
265. Li H, Liu Q, Wang N, Xu J. Correlation of different NADPH oxidase homologues with late endothelial progenitor cell senescence induced by angiotensin II: effect of telmisartan. Intern Med. 2011;50:1631-1642.
266. Vasa-Nicotera M, Chen H, Tucci P, Yang AL, Saintigny G, Menghini R, Mahe C, Agostini M, Knight RA, Melino G, Federici M. Mir-146a is modulated in human endothelial cell with aging. Atherosclerosis. 2011; 217:326-330.
267. Rueckschloss U, Villmow M, Klockner U. NADPH oxidase-derived superoxide impairs calcium transients and contraction in aged murine ventricular myocytes. Exp Gerontol. 2010;45:788-796.
268. Jaulmes A, Sansilvestri-Morel P, Rolland-Valognes G, Bernhardt F, Gaertner R, Lockhart BP, Cordi A, Wierzbicki M, Rupin A, Verbeuren TJ. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 mapk pathway in cultured human endothelial cells. Thromb Res. 2009;124:439-446.
269. Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, Kim F. Activation of nf-kappab by palmitate in endothelial cells: A key role for NADPH oxidase-derived superoxide in response to tlr4 activation. Arterioscler Thromb Vasc Biol. 2009;29: 1370-1375.
270. Moe KT, Yin NO, Naylynn TM, Khairunnisa K, Wutyi MA, Gu Y, Atan MS, Wong MC, Koh TH, Wong P. Nox2 and nox4 mediate tumour necrosis factor-alpha-induced ventricular remodelling in mice. J Cell Mol Med. 2011;15:2601-2613.
271. Ryu J, Lee CW, Shin JA, Park CS, Kim JJ, Park SJ, Han KH. Fcgammariia mediates c-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4. Cardiovasc Res 2007;75:555-565. (Pubitemid 47080970)
272. Ritsick DR, Edens WA, Finnerty V, Lambeth JD. Nox regulation of smooth muscle contraction. Free Radic Biol Med. 2007;43:31-38. (Pubitemid 46874833)
273. Zhang Q, Malik P, Pandey D, Gupta S, Jagnandan D, Belin de Chantemele E, Banfi B, Marrero MB, Rudic RD, Stepp DW, Fulton DJ. Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase. Arterioscler Thromb Vasc Biol. 2008;28:1627-1633.
274. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A. 1991;88:10045-10048. (Pubitemid 21915772)
275. Lassegue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol. 2010;30: 653-661.
276. Sirker A, Zhang M, Shah AM. NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol. 2011;106:735-747.
277. Zalba G, San Jose G, Moreno MU, Fortuno A, Diez J. NADPH oxidasemediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. Antioxidant Redox Signal. 2005;7:1327-1336. (Pubitemid 41232530)
278. Wingler K, Wunsch S, Kreutz R, Rothermund L, Paul M, Schmidt HH. Upregulation of the vascular NAD(P)H-oxidase isoforms nox1 and nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med. 2001;31:1456-1464. (Pubitemid 33145316)
279. Wang P, Tang F, Li R, Zhang H, Chen S, Liu P, Huang H. Contribution of different nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan. Pharmacol Res. 2007;55:408-417. (Pubitemid 46560393)
280. Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang GX, Yao L, Hitomi H, Shokoji T, Kiyomoto H, Kimura S, Tamaki T, Kohno M, Abe Y. Effects of at1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int. 2004;65:972-981. (Pubitemid 38251073)
281. Mollnau H, Wendt M, Szocs K, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cgmp signaling. Circ Res. 2002;90:E58-E65.
282. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: A study in nox1-deficient mice. Circulation. 2005;112:2677-2685. (Pubitemid 41532605)
283. Dikalova A, Clempus R, Lassegue B, Cheng G, McCoy J, Dikalov S, San Martin A, Lyle A, Weber DS, Weiss D, Taylor WR, Schmidt HH, Owens GK, Lambeth JD, Griendling KK. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation. 2005;112:2668-2676. (Pubitemid 41532604)
284. Dikalova AE, Gongora MC, Harrison DG, Lambeth JD, Dikalov S, Griendling KK. Upregulation of nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via enos uncoupling. Am J Physiol Heart Circ Physiol. 2010;299:H673-H679.
285. Yogi A, Mercure C, Touyz J, Callera GE, Montezano AC, Aranha AB, Tostes RC, Reudelhuber T, Touyz RM. Renal redox-sensitive signaling, but not blood pressure, is attenuated by nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension. 2008;51:500-506. (Pubitemid 351156439)
286. Wind S, Beuerlein K, Armitage ME, Taye A, Kumar AH, Janowitz D, Neff C, Shah AM, Wingler K, Schmidt HH. Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by nox1/2 is reversed by NADPH oxidase inhibition. Hypertension. 2010;56:490-497.
287. Datla SR, Griendling KK. Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension. 2010;56:325-330.
288. Cook-Mills JM. Reactive oxygen species regulation of immune function. Mol Immunol. 2002;39:497-498. (Pubitemid 35341487)
289. Cifuentes ME, Rey FE, Carretero OA, Pagano PJ. Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice. Am J Physiol Heart Circ Physiol. 2000;279:H2234-H2240.
290. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res. 2001;88:947-953. (Pubitemid 32441474)
291. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40:511-515.
292. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res. 2001;89: 408-414. (Pubitemid 34132656)
293. Zhou MS, Hernandez Schulman I, Pagano PJ, Jaimes EA, Raij L. Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension. 2006; 47:81-86. (Pubitemid 43177819)
294. Weber DS, Rocic P, Mellis AM, Laude K, Lyle AN, Harrison DG, Griendling KK. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2005;288:H37-H42. (Pubitemid 40023825)
295. Murdoch CE, Alom-Ruiz SP, Wang M, Zhang M, Walker S, Yu B, Brewer A, Shah AM. Role of endothelial nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Res Cardiol. 2011;106:527-538.
296. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res. 2004;95:210-216. (Pubitemid 38988688)
297. Peterson JR, Burmeister MA, Tian X, Zhou Y, Guruju MR, Stupinski JA, Sharma RV, Davisson RL. Genetic silencing of nox2 and nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension. 2009;54: 1106-1114.
298. Modlinger P, Chabrashvili T, Gill PS, Mendonca M, Harrison DG, Griendling KK, Li M, Raggio J, Wellstein A, Chen Y, Welch WJ, Wilcox CS. Rna silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension. 2006;47:238-244. (Pubitemid 43189769)
299. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449-2460. (Pubitemid 47529329)
300. Senchenkova EY, Russell J, Kurmaeva E, Ostanin D, Granger DN. Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis. Hypertension. 2011;58:959-965.
301. Akasaki T, Ohya Y, Kuroda J, Eto K, Abe I, Sumimoto H, Iida M. Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the reninangiotensin system. Hypertens Res. 2006;29:813-820. (Pubitemid 44842817)
302. Ray R, Murdoch CE, Wang M, Santos CX, Zhang M, Alom-Ruiz S, Anilkumar N, Ouattara A, Cave AC, Walker SJ, Grieve DJ, Charles RL, Eaton P, Brewer AC, Shah AM. Endothelial nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler Thromb Vasc Biol. 2011;31:1368-1376.
303. Paravicini TM, Chrissobolis S, Drummond GR, Sobey CG. Increased NADPH-oxidase activity and nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke. 2004;35:584-589. (Pubitemid 38174454)
304. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension. 2002;39:269-274. (Pubitemid 34165227)
305. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension. 2004;43:841-848. (Pubitemid 38405598)
306. Schmidt H, Hermans J, Schiffers P, Kleikers P, Radermacher K, Altenhofer S, Wingler K. NADPH oxidase as a pharmacological target in disease-relevant oxidative stress. Acta Physiologica. 2011;203(Suppl 687):O-22.
307. Gavazzi G, Deffert C, Trocme C, Schappi M, Herrmann FR, Krause KH. Nox1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension. 2007;50:189-196. (Pubitemid 46992019)
308. Sheehan AL, Carrell S, Johnson B, Stanic B, Banfi B, Miller FJ Jr. Role for nox1 NADPH oxidase in atherosclerosis. Atherosclerosis. 2011;216: 321-326.
309. Vendrov AE, Madamanchi NR, Niu XL, Molnar KC, Runge M, Szyndralewiez C, Page P, Runge MS. NADPH oxidases regulate cd44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. J Biol Chem. 2010;285:26545-26557.
310. Fenyo IM, Florea IC, Raicu M, Manea A. Tyrphostin ag490 reduces napdh oxidase activity and expression in the aorta of hypercholesterolemic apolipoprotein e-deficient mice. Vasc Pharmacol. 2011;54: 100-106.
311. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, Przybylowski P, Wierzbicki K, Korbut R, Harrison DG, Channon KM. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol. 2006;26:333-339. (Pubitemid 43732196)
312. Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Hayashi Y, Itoh H, Yokoyama M. Expression of NADH/NADPH oxidase p22(phox) in human coronary arteries. Circulation. 1999;100: 1494-1498. (Pubitemid 29461459)
313. Kalinina N, Agrotis A, Tararak E, Antropova Y, Kanellakis P, Ilyinskaya O, Quinn MT, Smirnov V, Bobik A. Cytochrome b558- dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2002; 22:2037-2043. (Pubitemid 36025211)
314. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, LeBoeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2000;20:1529-1535. (Pubitemid 30353884)
315. Judkins CP, Diep H, Broughton BR, Mast AE, Hooker EU, Miller AA, Selemidis S, Dusting GJ, Sobey CG, Drummond GR. Direct evidence of a role for nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in apoe-/- mice. Am J Physiol Heart Circ Physiol. 2010;298:H24-H32.
316. Hsich E, Segal BH, Pagano PJ, Rey FE, Paigen B, Deleonardis J, Hoyt RF, Holland SM, Finkel T. Vascular effects following homozygous disruption of p47(phox): An essential component of NADPH oxidase. Circulation. 2000;101:1234-1236. (Pubitemid 30158608)
317. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS. P47phox is required for atherosclerotic lesion progression in apoe(-/-) mice. J Clin Invest. 2001;108:1513-1522. (Pubitemid 33091989)
318. Chen Z, Keaney JF Jr, Schulz E, Levison B, Shan L, Sakuma M, Zhang X, Shi C, Hazen SL, Simon DI. Decreased neointimal formation in nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury. Proc Natl Acad Sci U S A. 2004;101: 13014-13019. (Pubitemid 39167575)
319. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q IV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. P22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45-51. (Pubitemid 27030367)
320. Gauss KA, Nelson-Overton LK, Siemsen DW, Gao Y, DeLeo FR, Quinn MT. Role of nf-kappab in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. J Leukoc Biol. 2007;82:729-741. (Pubitemid 47367165)
321. Ding H, Hashem M, Triggle C. Increased oxidative stress in the streptozotocin-induced diabetic apoe-deficient mouse: changes in expression of NADPH oxidase subunits and enos. Eur J Pharmacol. 2007;561:121-128. (Pubitemid 46435847)
322. Li J, Wang JJ, Yu Q, Chen K, Mahadev K, Zhang SX. Inhibition of reactive oxygen species by lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4. Diabetes. 2010; 59:1528-1538.
323. Tian XY, Wong WT, Xu A, Chen ZY, Lu Y, Liu LM, Lee VW, Lau CW, Yao X, Huang Y. Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress. Br J Pharmacol. 2011;164:598-606.
324. Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, Mangalat D, Hoch N, Dikalov S, Rudzinski P, Kapelak B, Sadowski J, Harrison DG. Calcium-dependent nox5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol. 2008;52:1803-1809.
325. Yun J, Rocic P, Pung YF, Belmadani S, Carrao AC, Ohanyan V, Chilian WM. Redox-dependent mechanisms in coronary collateral growth: The "redox window" hypothesis. Antioxidant Redox Signal. 2009;11: 1961-1974.
326. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, Lambeth JD. Reactive oxygen generated by nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A. 2002;99:715-720. (Pubitemid 34106576)
327. Komatsu D, Kato M, Nakayama J, Miyagawa S, Kamata T. NADPH oxidase 1 plays a critical mediating role in oncogenic ras-induced vascular endothelial growth factor expression. Oncogene. 2008;27: 4724-4732.
328. Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, Alexander RW. Role of gp91phox (nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation. 2005; 111:2347-2355. (Pubitemid 40647071)
329. Urao N, Inomata H, Razvi M, Kim HW, Wary K, McKinney R, Fukai T, Ushio-Fukai M. Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. Circ Res. 2008;103:212-220.
330. Haddad P, Dussault S, Groleau J, Turgeon J, Maingrette F, Rivard A. Nox2-derived reactive oxygen species contribute to hypercholesterolemia- induced inhibition of neovascularization: effects on endothelial progenitor cells and mature endothelial cells. Atherosclerosis. 2011;217: 340-349.
331. Ebrahimian TG, Heymes C, You D, Blanc-Brude O, Mees B, Waeckel L, Duriez M, Vilar J, Brandes RP, Levy BI, Shah AM, Silvestre JS. NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol. 2006;169:719-728. (Pubitemid 44156327)
332. Zhang M, Brewer AC, Schroder K, Santos CX, Grieve DJ, Wang M, Anilkumar N, Yu B, Dong X, Walker SJ, Brandes RP, Shah AM. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A. 2010;107:18121-18126.
333. Bhandarkar SS, Jaconi M, Fried LE, et al. Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice. J Clin Invest. 2009;119:2359-2365.
334. Jackman KA, Miller AA, Drummond GR, Sobey CG. Importance of nox1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke. Brain Res. 2009; 1286:215-220.
335. Kahles T, Kohnen A, Heumueller S, Rappert A, Bechmann I, Liebner S, Wittko IM, Neumann-Haefelin T, Steinmetz H, Schroeder K, Brandes RP. NADPH oxidase nox1 contributes to ischemic injury in experimental stroke in mice. Neurobiol Dis. 2010;40:185-192.
336. Walder CE, Green SP, Darbonne WC, Mathias J, Rae J, Dinauer MC, Curnutte JT, Thomas GR. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke. 1997;28:2252-2258. (Pubitemid 27497931)
337. Brait VH, Jackman KA, Walduck AK, Selemidis S, Diep H, Mast AE, Guida E, Broughton BR, Drummond GR, Sobey CG. Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, t lymphocytes, and nox2-derived superoxide. J Cereb Blood Flow Metab. 2010;30:1306-1317.
338. Bell RM, Cave AC, Johar S, Hearse DJ, Shah AM, Shattock MJ. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J. 2005;19:2037-2039. (Pubitemid 41759757)
339. Nisbet RE, Graves AS, Kleinhenz DJ, Rupnow HL, Reed AL, Fan TH, Mitchell PO, Sutliff RL, Hart CM. The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice. Am J Resp Cell Mol Biol. 2009;40:601-609.
340. Vallet P, Charnay Y, Steger K, Ogier-Denis E, Kovari E, Herrmann F, Michel JP, Szanto I. Neuronal expression of the NADPH oxidase nox4, and its regulation in mouse experimental brain ischemia. Neuroscience. 2005;132:233-238. (Pubitemid 40417898)
341. McCann SK, Dusting GJ, Roulston CL. Early increase of nox4 NADPH oxidase and superoxide generation following endothelin-1-induced stroke in conscious rats. J Neurosci Res. 2008;86:2524-2534.
342. Kleinschnitz C, Grund H, Wingler K, et al. Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol. 2010;8:e1000479.
343. Infanger DW, Cao X, Butler SD, Burmeister MA, Zhou Y, Stupinski JA, Sharma RV, Davisson RL. Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res. 2010; 106:1763-1774.
344. Bendall JK, Cave AC, Heymes C, Gall N, Shah AM. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation. 2002;105:293-296. (Pubitemid 34106175)
345. Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, Liao JK. Requirement of rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci U S A. 2006;103:7432-7437. (Pubitemid 43727850)
346. Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a nox2-containing NADPH oxidase. FASEB J. 2006;20:1546-1548.
347. Doerries C, Grote K, Hilfiker-Kleiner D, Luchtefeld M, Schaefer A, Holland SM, Sorrentino S, Manes C, Schieffer B, Drexler H, Landmesser U. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res. 2007;100:894-903. (Pubitemid 46555695)
348. Hoffmeyer MR, Jones SP, Ross CR, Sharp B, Grisham MB, Laroux FS, Stalker TJ, Scalia R, Lefer DJ. Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice. Circ Res. 2000;87:812-817.
349. Byrne JA, Grieve DJ, Bendall JK, Li JM, Gove C, Lambeth JD, Cave AC, Shah AM. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res. 2003;93:802-805.
350. Maytin M, Siwik DA, Ito M, Xiao L, Sawyer DB, Liao R, Colucci WS. Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox. Circulation. 2004;109:1168-1171. (Pubitemid 38332622)
351. Grieve DJ, Byrne JA, Siva A, Layland J, Johar S, Cave AC, Shah AM. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol. 2006;47:817-826. (Pubitemid 43243107)
352. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J. NADPH oxidase 4 (nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A. 2010;107:15565-15570.
353. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW. Novel role of gp91(phox)- containing NAD(P)H oxidase in vascular endothelial growth factorinduced signaling and angiogenesis. Circ Res. 2002;91:1160-1167. (Pubitemid 36076365)
354. Pendyala S, Usatyuk PV, Gorshkova IA, Garcia JG, Natarajan V. Regulation of NADPH oxidase in vascular endothelium: The role of phospholipases, protein kinases, and cytoskeletal proteins. Antioxidant Redox Signal. 2009;11:841-860.
355. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2008;102:488-496. (Pubitemid 351651106)
356. Spallarossa P, Altieri P, Garibaldi S, Ghigliotti G, Barisione C, Manca V, Fabbi P, Ballestrero A, Brunelli C, Barsotti A. Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in h9c2 cells: The role of map kinases and NAD(P)H oxidase. Cardiovasc Res. 2006;69:736-745. (Pubitemid 43139736)
357. Sorescu GP, Song H, Tressel SL, Hwang J, Dikalov S, Smith DA, Boyd NL, Platt MO, Lassegue B, Griendling KK, Jo H. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res. 2004;95:773-779. (Pubitemid 39390579)
358. Fan C, Kawai Y, Inaba S, Arakawa K, Katsuyama M, Kajinami K, Yasuda T, Yabe-Nishimura C, Konoshita T, Miyamori I. Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of nox1. J Steroid Biochem Mol Biol. 2008;111: 29-36.
359. Manea A, Tanase LI, Raicu M, Simionescu M. Jak/stat signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol. 2010;30: 105-112.
360. Briones AM, Tabet F, Callera GE, Montezano AC, Yogi A, He Y, Quinn MT, Salaices M, Touyz RM. Differential regulation of nox1, nox2 and nox4 in vascular smooth muscle cells from wky and shr. J Am Soc Hypertens. 2011;5:137-153.
361. Cevik MO, Katsuyama M, Kanda S, Kaneko T, Iwata K, Ibi M, Matsuno K, Kakehi T, Cui W, Sasaki M, Yabe-Nishimura C. The ap-1 site is essential for the promoter activity of nox1/NADPH oxidase, a vascular superoxide-producing enzyme: possible involvement of the erk1/2-junb pathway. Biochem Biophys Res Commun. 2008;374:351-355.
362. Katsuyama M, Fan C, Arakawa N, Nishinaka T, Miyagishi M, Taira K, Yabe-Nishimura C. Essential role of atf-1 in induction of nox1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem J. 2005;386:255-261. (Pubitemid 40343782)
363. Katsuyama M, Ozgur Cevik M, Arakawa N, Kakehi T, Nishinaka T, Iwata K, Ibi M, Matsuno K, Yabe-Nishimura C. Myocyte enhancer factor 2b is involved in the inducible expression of nox1/NADPH oxidase, a vascular superoxide-producing enzyme. FEBS J. 2007;274: 5128-5136. (Pubitemid 47481186)
364. Manea A, Tanase LI, Raicu M, Simionescu M. Transcriptional regulation of NADPH oxidase isoforms, nox1 and nox4, by nuclear factorkappab in human aortic smooth muscle cells. Biochem Biophys Res Commun. 2010;396:901-907.
365. Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nature Rev Drug Discover. 2011;10:453-471.
366. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G, Shah AM. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol. 2003;41:2164-2171. (Pubitemid 36724261)
367. Park YM, Lim BH, Touyz RM, Park JB. Expression of NAD(P)H oxidase subunits and their contribution to cardiovascular damage in aldosterone/salt- induced hypertensive rat. J Korean Med Sci. 2008;23: 1039-1045.
368. Meischl C, Krijnen PA, Sipkens JA, Cillessen SA, Munoz IG, Okroj M, Ramska M, Muller A, Visser CA, Musters RJ, Simonides WS, Hack CE, Roos D, Niessen HW. Ischemia induces nuclear nox2 expression in cardiomyocytes and subsequently activates apoptosis. Apoptosis. 2006; 11:913-921. (Pubitemid 43876822)
369. Maejima Y, Kuroda J, Matsushima S, Ago T, Sadoshima J. Regulation of myocardial growth and death by NADPH oxidase. J Mol Cell Cardiol. 2011;50:408-416.
370. Li JM, Shah AM. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem. 2002;277:19952- 19960. (Pubitemid 34967517)
371. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J, Orkin SH, Doerschuk CM, Dinauer MC. Mouse model of x-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet. 1995;9:202-209.
372. Muzaffar S, Shukla N, Angelini GD, Jeremy JY. NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells. J Cell Physiol. 2012;227:1941-1950.
373. Zhang L, Sheppard OR, Shah AM, Brewer AC. Positive regulation of the NADPH oxidase nox4 promoter in vascular smooth muscle cells by e2f. Free Radic Biol Med. 2008;45:679-685.
374. Diebold I, Petry A, Hess J, Gorlach A. The NADPH oxidase subunit nox4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell. 2010;21:2087-2096.
375. Pendyala S, Moitra J, Kalari S, Kleeberger SR, Zhao Y, Reddy SP, Garcia JG, Natarajan V. Nrf2 regulates hyperoxia-induced nox4 expression in human lung endothelium: identification of functional antioxidant response elements on the nox4 promoter. Free Radic Biol Med. 2011;50:1749-1759.
376. Goettsch C, Goettsch W, Brux M, Haschke C, Brunssen C, Muller G, Bornstein SR, Duerrschmidt N, Wagner AH, Morawietz H. Arterial flow reduces oxidative stress via an antioxidant response element and oct-1 binding site within the NADPH oxidase 4 promoter in endothelial cells. Basic Res Cardiol. 2011;106:551-561.
377. Goettsch C, Goettsch W, Muller G, Seebach J, Schnittler HJ, Morawietz H. Nox4 overexpression activates reactive oxygen species and p38 mapk in human endothelial cells. Biochem Biophys Res Commun. 2009;380: 355-360.
378. Carnesecchi S, Deffert C, Donati Y, Basset O, Hinz B, Preynat-Seauve O, Guichard C, Arbiser JL, Banfi B, Pache JC, Barazzone-Argiroffo C, Krause KH. A key role for nox4 in epithelial cell death during development of lung fibrosis. Antioxidant Redox Signal. 2011;15:607-619.
379. Manea A, Manea SA, Gafencu AV, Raicu M, Simionescu M. Ap-1- dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler Thromb Vasc Biol. 2008;28:878-885. (Pubitemid 351544102)
380. Djordjevic T, Pogrebniak A, BelAiba RS, Bonello S, Wotzlaw C, Acker H, Hess J, Gorlach A. The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells. Free Radic Biol Med. 2005;38:616-630. (Pubitemid 40416858)
381. Moriwaki K, Kiyomoto H, Hitomi H, Ihara G, Kaifu K, Matsubara K, Hara T, Kondo N, Ohmori K, Nishiyama A, Fukui T, Kohno M. Interferon-gamma enhances superoxide production in human mesangial cells via the jak-stat pathway. Kidney Int. 2006;70:788-793. (Pubitemid 44215356)
382. Li L, Frei B. Prolonged exposure to lps increases iron, heme, and p22phox levels and NADPH oxidase activity in human aortic endothelial cells: Inhibition by desferrioxamine. Arterioscler Thromb Vasc Biol. 2009;29:732-738.
383. Hitomi H, Fukui T, Moriwaki K, Matsubara K, Sun GP, Rahman M, Nishiyama A, Kiyomoto H, Kimura S, Ohmori K, Abe Y, Kohno M. Synergistic effect of mechanical stretch and angiotensin II on superoxide production via NADPH oxidase in vascular smooth muscle cells. J Hypertens. 2006;24:1089-1095. (Pubitemid 43772317)
384. Manea A, Manea SA, Gafencu AV, Raicu M. Regulation of NADPH oxidase subunit p22(phox) by nf-kb in human aortic smooth muscle cells. Arch Physiol Biochem. 2007;113:163-172.
385. Ni W, Zhan Y, He H, Maynard E, Balschi JA, Oettgen P. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II. Circ Res. 2007;101:985-994. (Pubitemid 350084976)
386. Honjo T, Otsui K, Shiraki R, Kawashima S, Sawamura T, Yokoyama M, Inoue N. Essential role of noxa1 in generation of reactive oxygen species induced by oxidized low-density lipoprotein in human vascular endothelial cells. Endothelium. 2008;15:137-141. (Pubitemid 351891378)